← Browse by Condition
Medical Condition
intestinal failure associated liver disease
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT05919680 Phase 2
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
Enrollment
36 pts
Location
United States
Sponsor
NorthSea Therapeutics B.V.
NCT07202910
Recruiting
VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients
Enrollment
550 pts
Location
Sweden
Sponsor
Sahlgrenska University Hospita...